Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide


  1. 1. Bibliography Books: A) Addiction: 1) Introduction to Addictive Behaviors, Third Edition (Guilford Substance Abuse Series) by Dennis L. Thombs; The Guilford Press; 3RD edition (March 14, 2006); 1593852789 2) Clinical Textbook of Addictive Disorders, Third Edition by Richard J. Frances (Editor), Sheldon Irvin Miller (Editor), Avram H. Mack (Editor); The Guilford Press; 3RD edition (May 18, 2005); 159385174X 3) Drugs, the Brain, and Behavior: The Pharmacology of Abuse and Dependence (Haworth Therapy for the Addictive Disorders) by John Brick, Carlton K. Erickson; Haworth Press (June 1998); 0789002744 4) Drugs of Abuse and Addiction: Neurobehavioral Toxicology by Raymond Niesink (Editor), R.M.A. Jaspers (Editor), L.M.W. Kornet (Editor), J.M. van Ree (Editor); CRC (December 8, 1998); 0849378036 5) Molecular Biology of Drug Addiction by Rafael Maldonado (Editor); Humana Press (September 1, 2002); 1588290603 6) Neurobiology of Addictions: Implications for Clinical Practice by Richard T. Spence (Editor), Diana M. Dinitto (Editor), Shulamith Lala Ashenberg Straussner (Editor); Haworth Social Work (February 2002); 0789016664 7) False Messengers: How Addictive Drugs Change the Brain by David P. Friedman, Sue Rusche; CRC (September 1, 1999); 978-9057025150 8) Handbook of the Medical Consequences of Alcohol and Drug Abuse by John Brick (Editor); 978-0789018632 9) Drugs of Abuse: Neurological Reviews and Protocols (Methods in Molecular Medicine) by John Q. Wang (Editor); Humana Press; 1 edition (December 11, 2002); 978- 1588290571
  2. 2. 10) Methods in Drug Abuse Research (Methods and New Frontiers in Neuroscience) by Barry D. Waterhouse (Editor); CRC (November 25, 2002); 978-0849323454 11) Molecular Biology of Drug Addiction by Rafael Maldonado (Editor); Humana Press; 1 edition (September 1, 2002); 978-1588290601 12) Review of General Psychiatry by Howard H. Goldman; McGraw-Hill Medical; 5th edition (June 29, 2000); 978-0838584347 13) Concepts of Chemical Dependency by Harold E. Doweiko; Wadsworth Publishing; 6 edition (July 6, 2005); 978-0534632847 B) The Brain: 1) The Embryonic Human Brain: An Atlas Of Developmental Stages by Ronan R. O'Rahilly, Fabiola Müller; Wiley-Liss; 3 edition; 0471694622 2) Neuroscience by Dale Purves (Editor), George J. Augustine (Editor), David Fitzpatrick (Editor), William C. Hall (Editor), Anthony-Samuel Lamantia (Editor), James O. McNamara (Editor), S. Mark Williams (Editor); Sinauer Associates; 3rd Bk&Cdr edition; 0878937250 3) Neuroscience: Exploring the Brain by Mark F Bear, Barry Connors, Michael Paradiso; Lippincott Williams & Wilkins; 3rd Pkg edition; 0781760038 4) Brain Imaging in Substance Abuse: Research, Clinical, and Forensic Applications (Forensic Science) by Joseph Frascella, Marc J.Kaufman (Editor); Humana Press; 1ST edition (January 15, 2001); 0896037703 5) Images of Human Behavior: A Brain SPECT Atlas by Daniel Amen; MindWorks Press (June 2004); 978-1886554047 6) Imaging Drug Action in the Brain by Edythe D. London; CRC (December 21, 1992); 978-0849388439
  3. 3. 7) Neurobiology of Mental Illness, by Dennis S. Charney, Eric J. Nestler, Benjamin S. Bunney; Oxford University Press, 1999, ISBN: 0-19-511265-2 8) Medical Neuroscience: An Approach to Anatomy, Pathology, and Physiology by Systems and Levels (Fourth Edition), by Eduardo E. Benarroch, Barbara F. Westmoreland, Jasper R. Daube, Thomas J. Reagan, and Burton A. Sandok; Lippincott, Williams, and Wilkins, 1999, ISBN: 0-7817-1426-5 9) Fundamental Neuroscience, Duane E. Haines (editor), Churchill Livingstone Pubs, 2nd edition (January 15, 2002); 978-0443066030 10) Medical Neuroscience by Stephen E. Nadeau, Tanya S. Ferguson, Edward Valenstein, Charles J. Vierck, Jeffrey C. Petruska, Wolfgang J. Streit, Louis A. Ritz; Saunders; Package edition (November 23, 2004); 978-1416024040 11) Neurobiology of Mental Illness by Eric J. Nestler; Oxford University Press, USA; 2 edition (July 21, 2005); 978-0195189803 12) Drugs and the Brain (Scientific American Library Series) by Solomon H. Snyder; W.H. Freeman & Company (May 1996); 978-0716760177 C) Reward Circuit: 1) Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders by Jeffrey L. Cummings (Editor); Guilford Press, 2001; 1572306238 2) Methods in Drug Abuse Research: Cellular and Circuit Level Analyses; by Barry D. Waterhouse (Editor); CRC; 1st edition (November 27, 2002); 0849323452 3) Brain Circuits and Functions of the Mind: Essays in Honor of Roger Wolcott Sperry, Author by Colwyn B. Trevarthern (Editor); Cambridge University Press (January 26, 1990); 0521378745
  4. 4. 4) Mind Wide Open: Your Brain and the Neuroscience of Everyday Life by Steven Johnson; Scribner; Reprint edition; 0743241665 5) Psychopharmacology: Drugs, the Brain and Behavior by Jerrold S. Meyer (Author), Linda F. Quenzer; Sinauer Associates (October 2004); 0878935347 D) Neurotransmitters: 1) The Dopamine Receptors by Kim A. Neve (Editor), Rachael L. Neve (Editor); Humana Press; 1st edition (January 15, 1997); 089603433X 2) CNS Neurotransmitters and Neuromodulators: Dopamine by Trevor W. Stone; CRC-Press; 1 edition (October 30, 1996); 0849376327 3) Dopamine, Volume 21 (Handbook of ChemicaL Neuroanatomy) by S.B. Dunnett (Editor), M. Bentivoglio (Editor), A. Björklund (Editor), T. Hökfelt (Editor); 0444517782 4) Dopamine Receptors and Transporters (Neurological Disease and Therapy) by Anita Sidhu (Editor), Marc Laruelle (Editor), Philippe Vernier (Editor); Informa Healthcare; 2 edition (January 31, 2003); 0824708547 5) Dopamine in the CNS II (Handbook of Experimental Pharmacology) by Gaetano Di Chiara (Editor); Springer; 1 edition (August 11, 2002); 3540427201 6) Progress in Dopamine Research Schizophrenia by Arvid Carlsson (Editor), Yves Lecrubier (Editor); Taylor & Francis (July 15, 2004); 1841844594 7) Dopamine in the Pathophysiology and Treatment of Schizophrenia by Shitij Kapur (Editor), Yves Lecrubier (Editor); Taylor & Francis; 2 edition (September 12, 2003); 1841843040 8) Dopamine Receptors and Transporters: Pharmacology, Structure, and Function by Hyman B. Niznik (Editor) ;
  5. 5. Marcel Dekker; 1st edition (January 15, 1994); 0824791584 9) Determinant of reinforcing efficacy of phenyltropanes: Onset of dopamine transporter occupancy by Sunmee Wee; ProQuest / UMI (March 19, 2006); 0542150115 10) Dopamine in the CNS I (Handbook of Experimental Pharmacology) by Gaetano Di Chiara (Editor); Springer; 1 edition (August 11, 2002); 3540427198 11) Neurotransmitters, Drugs and Brain Function by Roy Webster (Editor); John Wiley & Sons; 1st edition (November 15, 2001); 0471978191 12) Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects by Oliver von Bohlen und Halbach, Rolf Dermietzel; Wiley-VCH; 2 edition (November 29, 2006); 3527313079 13) Neurotransmitter Transporters (Handbook of Experimental Pharmacology) by Harald H. Sitte (Editor), Michael Freissmuth (Editor); Springer; 1 edition (June 14, 2006); 3540297839 14) Dendritic Neurotransmitter Release by Mike Ludwig (Editor); Springer; 1 edition (December 8, 2004); 0387229337 15) Effects of branched chain amino acid dopamine depletion on memory, attention, and executive functions in healthy males by Katharine W. Nassauer; ProQuest / UMI (March 20, 2006); 0542288397 16) Catecholamine Research: From Molecular Insights to Clinical Medicine (Advances in Behavioral Biology) by Toshiharu Nagatsu (Editor), Toshitaka Nabeshima (Editor), Richard McCarty (Editor), David S. Goldstein (Editor); Springer; 1 edition (October 31, 2002); 0306474034 17) Receptor Binding in Drug Research (Clinical Pharmacology Series, Vol 5) by A. O'brien; CRC (June 25, 1986); 0824775481
  6. 6. E) Psychopharmacology: 1) Molecular Basis of Neuropharmacology: A Foundation for Clinical Neuroscience by Eric J. Nestler, Steven E. Hyman, Robert C. Malenka; McGraw-Hill Medical; 1 edition (March 28, 2001); 0838563791 2) Clinical Manual Of Addiction Psychopharmacology by Henry R. Kranzler (Editor), Domenic A. Ciraulo (Editor); American Psychiatric Publishing, Inc.; 1 edition (August 1, 2005); 1585621323 3) The American Psychiatric Publishing Textbook of Psychopharmacology by Alan F. Schatzberg (Editor), Charles B. Nemeroff (Editor); American Psychiatric Publishing; 3RD edition (November 30, 2003); 1585620602 4) Handbook of Essential Psychopharmacology (Handbook of Essential Psychopharmacology) by Ronald W. Pies, Donald P. Rogers; American Psychiatric Publishing; 2nd edition (April 2005); 1585621684 5) Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care by Charles B. Nemeroff, Alan F. Schatzberg; American Psychiatric Publishing (December 15, 1999; 0880489901 6) Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (Essential Psychopharmacology Series) by Stephen M. Stahl, Nancy Muntner (Illustrator); Cambridge University Press; 2 edition (June 15, 2000); 0521646154 7) Psychopharmacology: An Introduction by René Spiegel; John Wiley & Sons; 4 edition (September 19, 2003); 0470846917 8) Case Studies in Psychopharmacology by David Taylor, Carol Paton; Taylor & Francis; 2 edition (May 30, 2002); 978-1841841540
  7. 7. 9) Psychopharmacology Case Studies by David S. Janowsky, Dominick Addario, S. Craig Risch; The Guilford Press; 2nd edition (March 23, 1987); 978-0898629217 10) Basic Concepts in Pharmacology by Janet L. Stringer; McGraw-Hill Professional; 3 edition (September 26, 2005); 978-0071458184 F) Individual Drugs: 1) Methamphetamine Use: Clinical and Forensic Aspects by Errol Yudko, Sandra B. McPherson, Harold V. Hall; CRC; 1 edition (June 26, 2003); 0849314771 2) New Research on Methamphetamine Abuse by Gerald. H Toolaney (Editor); Nova Science Publishers (August 2, 2006); 1600213782 3) A Clinician's Guide to Methamphetamine (Hazelden Professional Library) by Jeanne L. Obert, Michael J. McCann, Patricia, Ph.D. Marinelli-Casey; 1592851835 4) Methamphetamine Use by Harold V. Hall, Sandra B. McPherson, Errol Yudko; CRC; 2 edition (November 30, 2007); 0849372739 5) Amphetamine and Its Analogs: Psychopharmacology, Toxicology, and Abuse by Arthur K. Cho, David Simha Segal (Editor); Academic Press (March 1994); 0121733750 6) Cellular and Molecular Mechanisms of Drugs of Abuse II: Cocaine, Substituted Amphetamines, Gbh, and Opiates (Annals of the New York Academy of Sciences) by Syed F. Ali (Editor); New York Academy of Sciences (June 2002); 1573314080 7) The Neurochemistry of Drugs of Abuse: Cocaine, Ibogaine, and Substituted Amphetamines (Annals of the New York Academy of Sciences) by Syed F. Ali (Editor); New York Academy of Sciences (September 30, 2000); 0801865468
  8. 8. 8) The Neurobiology of Opiates (Physiology of Drug Abuse) by Jr., Ronald P. Hammer; CRC (November 24, 1992); 978- 0849379321 9) Prescription Drug Addiction: The Hidden Epidemic by Rod Colvin; Addicus Books; 1st edition (November 2001); 978- 1886039520 10) Prescription Drug Abuse (What's the Deal?) by Karla Fitzhugh; Heinemann (November 12, 2005); 978- 1403470249 11) Ecstasy : The Complete Guide : A Comprehensive Look at the Risks and Benefits of MDMA by Julie Holland; Park Street Press (August 1, 2001); 978-0892818570 12) Ketamine: Dreams and Realities by Karl Jansen; MAPS (December 1, 2004); 978-0966001976 G) History, Policy, and Sociological Aspects: 1) Dark Paradise: A History of Opiate Addiction in America by David T. Courtwright; Harvard University Press; Enl. ed. edition (May 31, 2001); 978-0674005853 2) Forces of Habit: Drugs and the Making of the Modern World by David T. Courtwright; Harvard University Press; New Ed edition (October 30, 2002); 978-0674010031 3) Opium: A History by Martin Booth; St. Martin's Griffin (June 12, 1999); 978-0312206673 4) A Brief History of Drugs: From the Stone Age to the Stoned Age by Antonio Escohotado, Ken Symington; Park Street Press (May 1, 1999); 978-0892818266 5) Drug Control in a Free Society by James B. Bakalar, Lester Grinspoon, Bakalar/Grinspoon; 978-0521357722 6) Culture on Drugs: Narco-cultural Studies of High Modernity by Dave Boothroyd; Manchester Univ Pr (April 30, 2007); 978-0719055980
  9. 9. Articles: 1. Baberg HT, Nelesen RA, Dimsdale JE: Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry 1996; 153:789-793[Abstract] 2. Murray JB: Psychophysiological aspects of amphetamine- methamphetamine abuse. J Psychol 1998; 132:227- 237[Medline] 3. Shaw KP: Human methamphetamine-related fatalities in Taiwan during 1991-1996. J Forensic Sci 1999; 44:27-31[Medline] 5. Sato M, Numach Y, Hamamura T: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992; 18:115-122[Medline] 6. Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y, Horita N, Kaneko T: Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan: a preliminary report. Acta Psychiatr Scand 1994; 89:428-432[Medline] 7. Iyo M, Sekine Y, Matsunaga T, Tsukamoto T, Takei N, Mori N: Methamphetamine-associated obsessional symptoms and effective risperidone treatment: a case report. J Clin Psychiatry 1999; 60:337-338 8. Buffenstein A, Heaster J, Ko P: Chronic psychotic illness from methamphetamine (letter). Am J Psychiatry 1999; 156:662[Free Full Text] 10. Wolters EC: Dopaminomimetic psychosis in Parkinson’s disease patients: diagnosis and treatment. Neurology 1999; 52(suppl 3):10-13 11. Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148:1474-1486 12. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG: Hyperlocomotion and indifference to cocaine and amphetamine
  10. 10. in mice lacking the dopamine transporter. Nature 1996; 379:606-612[CrossRef][Medline] 13. Rudnick G: Mechanisms of biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters. Edited by Reith MEA. Totowa, NJ, Humana Press, 1997, pp 73- 100 14. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ: Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2:699- 703[CrossRef][Medline] 15. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA: Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN- 35,428. J Neurosci 1998; 18:8417-8422[Abstract/Free Full Text] 16. Scheffel U, Boja JW, Kuhar MJ: Cocaine receptors: in vivo labeling with [3H](-)cocaine, [3H]WIN 35,065-2 and [3H]WIN 35,428. Synapse 1989; 4:390-392[CrossRef][Medline] 18. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812 19. Mohr P, Horacek J, Motlova L, Libiger J, Czobor P: Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia. Schizophr Res 1998; 30:91-99[CrossRef][Medline] 20. Borg V: Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr Scand 1983; 68:100-110[Medline] 21. Yamashita T, Uchida H, Okada H, Kurono T, Takemori T, Watanabe M, Shimizu K, Yoshikawa E, Ohmura T, Satoh N, Tanaka E, Nohara N, Tomitani T, Yamamoto M, Murayama H, Endo M: Development of a high resolution PET. IEEE Trans Nucl Sci 1990; 37:594-599[CrossRef] 22. Iyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, Sudo Y, Suzuki K, Irie T: Measurement of acetylcholinesterase by positron emission tomography in the
  11. 11. brains of healthy controls and patients with Alzheimer’s disease. Lancet 1997; 349:1805-1809 23. Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M: Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson’s disease: compartment analysis for ß-CFT binding with positron emission tomography. Ann Neurol 1999; 45:601-610[CrossRef][Medline] 24. Farde L, Pauli S, Hall H, Eriksson L, Halldin C, Hogberg T, Nilsson L, Sjogren I, Stone-Elander S: Stereoselective binding of 11C-raclopride in living human brain: a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology (Berl) 1988; 94:471-478[CrossRef][Medline] 25. Poole R, Brabbins C: Drug induced psychosis. Br J Psychiatry 1996; 168:135-138[Medline] 26. Allard P, Eriksson K, Ross SB, Marcusson JO: Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs. Psychopharmacology (Berl) 1990; 102:291- 294[CrossRef][Medline] 27. Rivest R, Falardeau P, Di Paolo T: Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 1995; 692:269-272[CrossRef][Medline] 28. Meng Y, Dukat M, Bridgen DT, Martin BR, Lichtman AH: Pharmacological effects of methamphetamine and other stimulants via inhalation exposure. Drug Alcohol Depend 1999; 53:111-120[CrossRef][Medline] 29. Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M: Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993; 21:717-723[Abstract] 30. Andreasen NC, O’Leary DS, Cizadlo T, Arndt S, Rezai K, Boles Ponto LL, Watkins GL, Hichwa RD: Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 1996; 93:9985-9990[Abstract/Free Full Text]
  12. 12. 31. Melchitzky DS, Lewis DA: Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum: evidence for a lobular- and laminar-specific dopamine innervation. Neuropsychopharmacology 2000; 22:466-472[CrossRef][Medline] 32. Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB, Ravert HT, Musachio J, McCann UD, Ricaurte GA: Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 1998; 18:419-427[Abstract/Free Full Text] 34. Wise RA, Hoffman DC: Localization of drug reward mechanisms by intracranial injections. Synapse 1992; 10:247- 263[CrossRef][Medline] 35. Iyo M, Nishio M, Itoh T, Fukuda H, Suzuki K, Yamasaki T, Fukui S, Tateno Y: Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography. Psychiatry Res Neuroimaging 1993; 50:217-231[CrossRef] 36. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D: Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990; 147:719-724[Abstract] 37. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Hitzemann R, Smith G, Fields SD, Gur R: Dopamine transporters decrease with age. J Nucl Med 1996; 37:554- 559[Abstract] 38. Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC: Iodine-123-N-omega- fluoropropyl-2ß-carbomethoxy-3ß-(4-iodophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson’s disease. J Nucl Med 1998; 39:1143-1148 39. Caine ED, Shoulson I: Psychiatric syndromes in Huntington’s disease. Am J Psychiatry 1983; 140:728- 733[Abstract]
  13. 13. 40. Bhatia KP, Marsden CD: The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994; 117:859-876[Abstract/Free Full Text] 41. Laakso A, Vilkman H, Kajander J, Bergman J, Haaparanta M, Solin O, Hietala J: Prediction of detached personality in healthy subjects by low dopamine transporter binding. Am J Psychiatry 2000; 157:290-292[Abstract/Free Full Text] 42. Hastings TG, Lewis DA, Zigmond MJ: Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 1996; 93:1956-1961[CrossRef] 43. Berman SB, Zigmond MJ, Hastings TG: Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 1996; 67:593-600[Medline] 44. Kuczenski R, Segal DS: Neurochemistry of amphetamine, in Amphetamine and Its Analogs. Edited by Cho AK, Segal DS. San Diego, Academic Press, 1994, pp 81-113 45. Meltzer CC, Price JC, Mathis CA, Greer PJ, Cantwell MN, Houck PR, Mulsant BH, Ben-Eliezer D, Lopresti B, DeKosky ST, Reynolds CF III: PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry 1999; 156:1871-1878 46. Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, di Bella D, Smeraldi E: Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 1999; 156:1450-1452 47. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA: Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996; 153:174-182; correction, 153:588[Abstract]